Search in:

Therapeutics and Clinical Risk Management Volume 15, 2019 - Issue

Submit an article Journal homepage

Open access

420

Views

CrossRef citations to date

Altmetric

Review

The importance of early identification of infusion-related reactions to monoclonal antibodies

Macarena C Cáceres1 Department of Nursing, University of Extremadura, Badajoz, SpainCorrespondence[email protected]

Jorge Guerrero-Martín1 Department of Nursing, University of Extremadura, Badajoz, Spain

Demetrio Pérez-Civantos2 Department of Biomedicine, University of Extremadura, Badajoz, Spain;3 Intensive Care Medicine Department, University Hospital of Badajoz, Servicio Extremeño de Salud, Badajoz, Spain

Patricia Palomo-López1 Department of Nursing, University of Extremadura, Badajoz, Spain

Juan Ignacio Delgado-Mingorance4 Oncology Department, University Hospital of Badajoz, Servicio Extremeño de Salud, Badajoz, Spain

Noelia Durán-Gómez1 Department of Nursing, University of Extremadura, Badajoz, Spain

Pages 965-977 | Published online: 01 Aug 2019

Cite this article
CrossMark

Full Article
Figures & data
References
Citations
Metrics
Licensing
Reprints & Permissions
View PDF PDF View EPUB EPUB

Citations (14)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Articles from other publishers (14)

Keunchil Park, Joshua K. Sabari, Eric B. Haura, Catherine A. Shu, Alexander Spira, Ravi Salgia, Karen L. Reckamp, Rachel E. Sanborn, Ramaswamy Govindan, Joshua M. Bauml, Joshua C. Curtin, John Xie, Amy Roshak, Patricia Lorenzini, Dawn Millington, Meena Thayu, Roland E. Knoblauch & Byoung Chul Cho. (2023) Management of infusion-related reactions (IRRs) in patients receiving amivantamab in the CHRYSALIS study. Lung Cancer 178, pages 166-171.
Crossref

Edward C. Tidswell. (2023) A Nontrivial Analysis of Patient Safety Risk from Parenteral Drug- and Medical Device-Borne Endotoxin. Drugs in R&D 23:1, pages 65-76.
Crossref

Jaume Mora, Godfrey C. Chan, Daniel A. Morgenstern, Karsten Nysom, Melissa K. Bear, Karen Tornøe & Brian H. Kushner. (2022) Outpatient administration of naxitamab in combination with granulocyte‐macrophage colony‐stimulating factor in patients with refractory and/or relapsed high‐risk neuroblastoma: Management of adverse events. Cancer Reports 6:1.
Crossref

Cabello Alemán Lucía. (2022) Future directions in cancer immunotherapy with monoclonal antibodies. Research Results in Pharmacology 8:4, pages 101-107.
Crossref

Fiammetta Vanoli & Renato Mantegazza. (2022) Antibody Therapies in Autoimmune Neuromuscular Junction Disorders: Approach to Myasthenic Crisis and Chronic Management. Neurotherapeutics 19:3, pages 897-910.
Crossref

Sarah B. Dubbs, Cheyenne Falat & Lauren Rosenblatt. (2022) Immune-based Therapies—What the Emergency Physician Needs to Know. Emergency Medicine Clinics of North America 40:1, pages 135-148.
Crossref

Beate Bittner & Johannes Schmidt. 2022. Formulation and Device Lifecycle Management of Biotherapeutics. Formulation and Device Lifecycle Management of Biotherapeutics 153 174 .

Beate Bittner & Johannes Schmidt. 2022. Formulation and Device Lifecycle Management of Biotherapeutics. Formulation and Device Lifecycle Management of Biotherapeutics 175 200 .

Jenai Wilmoth, Kathleen Colson, Franck Dubin & Christine Kellam. (2021) Isatuximab: Nursing Considerations for Use in the Treatment of Multiple Myeloma. Clinical Journal of Oncology Nursing 25:6, pages 706-712.
Crossref

Macarena Cáceres, Demetrio Pérez-Civantos, Jorge Guerrero-Martín, Marta Delgado, Casimiro Jurado & Noelia Durán-Gómez. (2021) Depressive Symptoms and Quality of Life Associated With the Use of Monoclonal Antibodies in Breast Cancer Treatment. Oncology Nursing Forum 48:5, pages 535-545.
Crossref

Julie R Brahmer, Hamzah Abu-Sbeih, Paolo Antonio Ascierto, Jill Brufsky, Laura C Cappelli, Frank B Cortazar, David E Gerber, Lamya Hamad, Eric Hansen, Douglas B Johnson, Mario E Lacouture, Gregory A Masters, Jarushka Naidoo, Michele Nanni, Miguel-Angel Perales, Igor Puzanov, Bianca D Santomasso, Satish P Shanbhag, Rajeev Sharma, Dimitra Skondra, Jeffrey A Sosman, Michelle Turner & Marc S Ernstoff. (2021) Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immune checkpoint inhibitor-related adverse events. Journal for ImmunoTherapy of Cancer 9:6, pages e002435.
Crossref

Panagiotis Gklinos, Miranta Papadopoulou, Vid Stanulovic, Dimos D. Mitsikostas & Dimitrios Papadopoulos. (2021) Monoclonal Antibodies as Neurological Therapeutics. Pharmaceuticals 14:2, pages 92.
Crossref

Iago Dillion Lima Cavalcanti & José Cleberson Santos SoaresIago Dillion Lima Cavalcanti & José Cleberson Santos Soares. 2021. Advances in Cancer Treatment. Advances in Cancer Treatment 57 78 .

Robert Kernstock, Gizette Sperinde, Deborah Finco, Roslyn Davis & Diana Montgomery. (2020) Clinical Immunogenicity Risk Assessment Strategy for a Low Risk Monoclonal Antibody. The AAPS Journal 22:3.
Crossref

Share icon
Back to Top

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.

People also read
Recommended articles
Cited by

To cite this article:

Reference style: APA Chicago Harvard

Citation copied to clipboard

Reference styles above use APA (6th edition), Chicago (16th edition) & Harvard (10th edition)

Download citation

Download a citation file in RIS format that can be imported by citation management software including EndNote, ProCite, RefWorks and Reference Manager.

Choose format: RIS BibTex RefWorks Direct Export

Choose options: Citation Citation & abstract Citation & references

The importance of early identification of infusion-related reactions to monoclonal antibodies

Articles from other publishers (14)

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

The importance of early identification of infusion-related reactions to monoclonal antibodies

Citations (14)

Articles from other publishers (14)

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date